| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of recurrent thrombocytopenia involving divergent immune-related mechanisms associated with pembrolizumab
|
Matsumoto, Shunya
|
|
|
131 |
C |
p. 104-107
|
artikel
|
| 2 |
A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials
|
Berger, Martin D.
|
|
|
131 |
C |
p. 89-97
|
artikel
|
| 3 |
A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation
|
Lala, Mallika
|
|
|
131 |
C |
p. 68-75
|
artikel
|
| 4 |
Chimeric antigen receptor (CAR) T-cells on the march: from diffuse large B-cell lymphoma to mantle cell lymphoma
|
Houot, Roch
|
|
|
131 |
C |
p. 51-52
|
artikel
|
| 5 |
Comment on ‘Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines’
|
Peris, Ketty
|
|
|
131 |
C |
p. 100-103
|
artikel
|
| 6 |
Comment on “Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines”
|
van Delft, Lieke C.J.
|
|
|
131 |
C |
p. 98-99
|
artikel
|
| 7 |
Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis
|
Chorti, Eleftheria
|
|
|
131 |
C |
p. 18-26
|
artikel
|
| 8 |
Early detection and management of immune-related myocarditis: Experience from a case with advanced squamous cell lung carcinoma
|
Tu, Li
|
|
|
131 |
C |
p. 5-8
|
artikel
|
| 9 |
Immune thrombocytopenia of haematological immune-related adverse events in cancer immunotherapy: Most and mighty
|
Pang, Xiaocong
|
|
|
131 |
C |
p. 16-17
|
artikel
|
| 10 |
Impact of antibiotic use during curative treatment of locally advanced head and neck cancers with chemotherapy and radiotherapy
|
Nenclares, Pablo
|
|
|
131 |
C |
p. 9-15
|
artikel
|
| 11 |
Reducing pain and distress related to needle procedures in children with cancer: A clinical practice guideline
|
Loeffen, Erik A.H.
|
|
|
131 |
C |
p. 53-67
|
artikel
|
| 12 |
Successful management of refractory immune-mediated enterocolitis with cyclosporine
|
Pesántez, David
|
|
|
131 |
C |
p. 37-39
|
artikel
|
| 13 |
The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report
|
Thomas, Gillian
|
|
|
131 |
C |
p. 76-88
|
artikel
|
| 14 |
Toxic epidermal necrolysis accompanied by several immune-related adverse events developed after discontinuation of nivolumab
|
Watanabe, Yuko
|
|
|
131 |
C |
p. 1-4
|
artikel
|
| 15 |
Tumour mutational burden as a biomarker for immunotherapy: Current data and emerging concepts
|
Fumet, Jean-David
|
|
|
131 |
C |
p. 40-50
|
artikel
|
| 16 |
Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non–small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study
|
Cortot, Alexis B.
|
|
|
131 |
C |
p. 27-36
|
artikel
|
Tijdschrift beschrijving